Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.96% | 56.81% | 11.99% | -6.99% | 9.75% |
| Total Other Revenue | -- | -- | -200.00% | -150.00% | -150.00% |
| Total Revenue | 22.97% | 56.82% | 11.99% | -7.00% | 9.74% |
| Cost of Revenue | 20.74% | 21.83% | -14.01% | -4.51% | 16.83% |
| Gross Profit | 24.52% | 93.13% | 36.42% | -8.64% | 5.24% |
| SG&A Expenses | -6.15% | 3.85% | 12.91% | -1.25% | -10.26% |
| Depreciation & Amortization | 3.28% | 3.28% | 8.62% | 10.71% | 12.96% |
| Other Operating Expenses | 409.50% | 400.32% | -425.67% | 202.40% | -191.42% |
| Total Operating Expenses | 16.48% | 15.30% | -6.47% | 2.39% | -8.54% |
| Operating Income | 23.23% | 94.37% | 99.92% | -66.50% | 54.74% |
| Income Before Tax | 26.72% | 95.92% | 102.87% | -4.37% | 46.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.72% | 95.92% | 102.87% | -4.37% | 46.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.72% | 95.92% | 102.87% | -4.37% | 46.40% |
| EBIT | 23.23% | 94.37% | 99.92% | -66.50% | 54.74% |
| EBITDA | 23.66% | 95.20% | 101.26% | -67.38% | 55.16% |
| EPS Basic | 38.99% | 96.69% | 92.72% | -0.25% | 44.38% |
| Normalized Basic EPS | 45.88% | 97.08% | 93.81% | -59.65% | 16.38% |
| EPS Diluted | 38.99% | 96.69% | 92.72% | -0.25% | 44.38% |
| Normalized Diluted EPS | 45.88% | 97.08% | 93.81% | -59.65% | 16.38% |
| Average Basic Shares Outstanding | 14.86% | 16.48% | 11.92% | 5.10% | 2.30% |
| Average Diluted Shares Outstanding | 14.86% | 16.48% | 11.92% | 5.10% | 2.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |